JMPWA
CORT icon

JP Morgan Private Wealth Advisors’s Corcept Therapeutics CORT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,493
Closed -$227K – 1562
2023
Q1 		$227K Buy
+10,493
New +$230K ﹤0.01% 1784

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

JP Morgan Private Wealth Advisors's CORT Position: Q2 2023 in Review

JP Morgan Private Wealth Advisors sold out of Corcept Therapeutics (CORT) in Q2 2023, closing a stake of 10,493 shares — an estimated $227K sold.

JP Morgan Private Wealth Advisors first reported a position in CORT in Q1 2023 and held it in 1 quarter. The position peaked at $227K in Q1 2023. 225 funds tracked by Wall St. Rank hold CORT as of Q2 2023.

  • JP Morgan Private Wealth Advisors reported no remaining Corcept Therapeutics position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 10,493 Corcept Therapeutics shares in Q2 2023, an estimated $227K.
  • JP Morgan Private Wealth Advisors first reported a position in Corcept Therapeutics in Q1 2023 and held it in 1 quarter.
  • JP Morgan Private Wealth Advisors's Corcept Therapeutics position peaked at $227K in Q1 2023.
  • 225 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.